Uncategorized August 26, 2013 Cure for cystic fibrosis comes closer to reality Washington: A group of researchers have made a significant breakthrough for figuring out which mutations are benign and which are… admin Love0
Uncategorized August 26, 2013 Business Rx: Breaking up with a mentor? Do it slowly – The Washington Post Q:I am in the mid-stages of my career. I’ve been climbing the corporate ladder for a while with some success.… admin Love0
Uncategorized August 26, 2013 AstraZeneca – MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire… admin Love0
Uncategorized August 23, 2013 BioHealth Innovation has its First-Ever Crab Feast On Wednesday August 21st, 80+ people filled the BHI parking lot for an evening of networking, eating crabs, and enjoying… admin Love0
Uncategorized August 23, 2013 Venture capital? No thanks. Mhelpdesk’s no-VC rule has upside, as well as risk – Washington Business Journal Only in the distorted reality of startups and venture capital would this plan seem daring: Mhelpdesk.com LLC is refusing outside… admin Love0
Uncategorized August 19, 2013 BHI is looking to fill a Health IT Entrepreneur-in-Residence Position Immediately Do you want to help change the face of the Maryland Biohealth Community? Are you an experienced entrepreneur itching to… admin Love0
Uncategorized August 19, 2013 Person-Centered Outcomes Research Resource (U2C) – Sept 26, 2013 ... Funding Opportunity Number: RFA-CA-13-008 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: EducationFood and NutritionHealth… Super User Love0
Uncategorized August 19, 2013 NIH Exploratory/Developmental Research Grant Program (Parent R21) ... Funding Opportunity Number: PA-11-261 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: EducationHealthIncome Security and Social… Super User Love0
Uncategorized August 16, 2013 Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44)- Jan 07, 2016 ... Funding Opportunity Number: PA-13-092 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: Health CFDA Number: 93.351… Super User Love0